Umbilical cord blood collection: Techniques and clinical indication
1 Blood Transfusion Centre, Mohamed V Military Hospital, Rabat, Morocco.
2 Central Hematology Laboratory-CHU Ibn Sina, Rabat, Morocco.
3 Faculty of Medicine and Pharmacy of Rabat, Mohammed V University, Rabat, Morocco.
Review Article
World Journal of Advanced Research and Reviews, 2024, 23(01), 2554–2558
Publication history:
Received on 16 June 2024; revised on 23 July 2024; accepted on 25 July 2024
Abstract:
Umbilical cord blood (UCB) is a useful source of hematopoietic stem cells, offering impressive advantages over other stem cell sources, including ease of production and reduced incidence of graft-versus-host disease. This review discusses advanced wire blood production techniques, evaluates its current medical applications, and addresses the technical and moral in this field. It highlights the therapeutic potential of metallic blood in the treatment of hematological diseases, genetic disorders and immunodeficiency, and explores new therapeutic areas, including regenerative medicine and autoimmune diseases. Future prospects focus on technological improvements to increase cell yield and viability, expand medical testing and develop global regulatory standards. In particular, through collaborative efforts in technology and ethics, umbilical cord blood can advance disease treatment paradigms and improve the outcomes of regenerative cures.
Keywords:
Cord Blood Sampling; Hematopoietic Stem Cells (HSCs); Cord Blood Transplantation (CBT); Graft-versus-Host Disease (GvHD); Regenerative Medicine.
Full text article in PDF:
Copyright information:
Copyright © 2024 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0